Marker Therapeutics
MRKR
74 hedge funds and large institutions have $75.8M invested in Marker Therapeutics in 2021 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 17 increasing their positions, 25 reducing their positions, and 16 closing their positions.
471% more call options, than puts
Call options by funds: $2.53M | Put options by funds: $443K
33% more capital invested
Capital invested by funds: $56.8M → $75.8M (+$19M)
0.07% more ownership
Funds ownership: 3.2% → 3.27% (+0.07%)
0% more funds holding
Funds holding: 74 → 74 (0)
0% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 16
32% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Advisers
New York
|
+$3.19M |
| 2 |
Millennium Management
New York
|
+$3.01M |
| 3 |
Two Sigma Investments
New York
|
+$2.35M |
| 4 |
D.E. Shaw & Co
New York
|
+$1.59M |
| 5 |
Renaissance Technologies
New York
|
+$1.05M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$4.79M |
| 2 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$3.18M |
| 3 |
State Street
Boston,
Massachusetts
|
-$1.01M |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$580K |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$431K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
AllianceBernstein
Nashville,
Tennessee
| – | -$66K | -2,950 | Closed |
|
77
RhumbLine Advisers
Boston,
Massachusetts
| – | -$57K | -2,531 | Closed |
|
78
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$45K | -1,997 | Closed |
|
|
MM
79
Meridian Management
Little Rock,
Arkansas
| – | -$44K | -1,956 | Closed |
|
|
AIG
80
American International Group
New York
| – | -$40 | -1,775 | Closed |
|
81
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$33K | -1,514 | Closed |
|
82
Squarepoint
New York
| – | -$24K | -1,086 | Closed |
|
83
Legal & General Group
London,
United Kingdom
| – | -$6K | -274 | Closed |
|
|
AIP
84
Ameritas Investment Partners
Lincoln,
Nebraska
| – | -$5K | -239 | Closed |
|
85
Citigroup
New York
| – | -$6.19K | -235 | -97% |
|
|
EP
86
Eudaimonia Partners
Winchester,
Tennessee
| – | -$3K | -150 | Closed |
|
|
PHK
87
Point72 Hong Kong
Hong Kong
| – | -$1K | -54 | Closed |
|
|
SFS
88
Sowell Financial Services
North Little Rock,
Arkansas
| – | -$1K | -50 | Closed |
|
|
VCM
89
Versant Capital Management
Phoenix,
Arizona
| – | +$395 | +15 | New |
|
MRKR Hedge Fund Activity: Q2 2021 in Review
74 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Marker Therapeutics (MRKR) for Q2 2021, worth a combined $75.8M — up 33% from $56.8M a quarter earlier.
Fund positioning in MRKR was balanced in Q2 2021: 16 funds opened new positions, 16 closed out, 17 added to existing stakes and 25 trimmed.
The largest buyer was Two Sigma Advisers, adding an estimated $3.19M. The largest seller was BlackRock, cutting an estimated $4.79M.
- 74 institutional investors held Marker Therapeutics (MRKR) as of Q2 2021, unchanged from Q1 2021.
- Funds reported $75.8M of Marker Therapeutics stock for Q2 2021, up 33% quarter-over-quarter.
- 16 funds opened new Marker Therapeutics positions in Q2 2021 and 16 closed out, a net change of 0 holders.
- The largest Marker Therapeutics buyer in Q2 2021 was Two Sigma Advisers, an estimated $3.19M added.
- The largest Marker Therapeutics seller in Q2 2021 was BlackRock, an estimated $4.79M sold.
Based on aggregated 13F filings for Q2 2021.